Thrombolysis for Cerebral Ischemia
Open Access
- 1 January 2010
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 1, 139
Abstract
The care for patients with acute ischemic stroke has been revolutionized by the clinical application of fibrinolysis. Intravenous recombinant tissue plasminogen activator (rt-PA) has been proven to improve functional outcomes following acute ischemic stroke and can be administered to a select group of patients up to 4.5 h after symptom onset. Time from symptom onset to thrombolysis is the most important determinant of the success of treatment, with greatest efficacy if given within 90 min. Hospitals should implement standardized processes and protocols for acute stroke to guide immediate patient assessment, brain imaging, drug administration, and post-thrombolysis care. In this article we review the clinical application of thrombolysis, care of acute stroke patients, current evidence regarding fibrinolysis, and future direction of penumbral imaging to select candidates for reperfusion therapies.Keywords
This publication has 39 references indexed in Scilit:
- Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemiaNeurology, 2010
- Outcomes of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 90 Years or OlderMayo Clinic Proceedings, 2009
- Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled studyThe Lancet Neurology, 2009
- Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery StrokeStroke, 2007
- The Interventional Management of Stroke (IMS) II StudyStroke, 2007
- Guidelines for the Early Management of Adults With Ischemic StrokeStroke, 2007
- Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS)Stroke, 2006
- Acute Hyperglycemia State Is Associated With Lower tPA-Induced Recanalization Rates in Stroke PatientsStroke, 2005
- Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activatorJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke.Stroke, 1992